In this paper, we address the rate control, the Medium Access Control (MAC) and the routing problem for cooperative Vehicular Ad-Hoc Network (VANET) in the framework of cross-layer design. At first, we introduce the cooperative communication conception to VANET, and propose an opportunistic cooperation strategy to improve the system performance. And then, we develop a cross-layer solution which consists of the link capacity detection with adjusting persistence probability at the MAC Layer, the flow rate control with the maximal utility at the Transport Layer and the routing design at the Network Layer. This proposal is designed in distributed manner in order to support a simple and efficient implementation for VANET. Furthermore, some practical issues, such as fairness and network cost, are presented for implementing the proposed solution and improving the system performance. Simulation results show that the proposed opportunistic cooperation strategy combined with joint control algorithm achieves the desired performance over VANET.
Herein, we propose the fabrication of polyethyleneimine-functionalized PdOs bimetallene (PdOs@PEI bimetallene) for alkaline oxygen reduction reaction (ORR) via wet-chemical method. The PdOs@PEI bimetallene has an ultra-thin and curved nanosheet structure...
Abstract-An important issue for supporting multimedia applications in multiple heterogeneous networks, a typical pervasive computing environment, is how to optimize the rate allocation by intelligently utilizing the available network resources while, at the same time, to meet each application's QoS (Quality of Service) requirement. In this work, we develop and evaluate a rate allocation scheme in terms of audio and video applications based on a cross-layer design framework. At first, we construct a general distortion model according to the observed parameters in each network, as well as each application's rate-distortion characteristic. Then, the rate allocation is formulated as a convex optimization problem that minimizes the sum of the expected distortion of all applications. Furthermore, the realization of the distributed rate allocation algorithm for achieving an optimal or close-to-optimal end-to-end QoS under the overall limited resource budget is the highlight of this paper. Simulation results are provided which demonstrate the effectiveness of our proposed distributed rate allocation scheme.
To assess the efficacy of allogeneic hematopoietic stem cell transplantation (allo-HSCT) for severe aplastic anemia (SAA) patients with infection, we conducted a retrospective study on 65 SAA patients with infection who received allo-HSCT from August 2012 to December 2016. All patients received antibacterial and/or antifungal therapy before transplantation. The infection status after initial anti-infection therapy was classified as complete response (CR) (n = 14) or partial response/stable disease (PR/SD) (n = 51) before transplantation. The median times for myeloid engraftment in the PR/SD and CR groups were 10.5 days (range, 7 to 22) and 10 days (range, 8 to 11), with cumulative incidences of 98% and 100%, respectively. With a median follow-up of 788 days (range, 181 to 1758), patients with PR/SD had comparable results for 3-year estimated overall survival (85.4% versus 92.9%, P = .530) and 3-year failure-free survival (82.7% versus 92.9%, P = .458) with 14 patients with CR who received contemporaneous transplantation. In multivariate analysis, poor survival outcomes for the entire cohort was significantly associated with poor pretransplantation performance status. This retrospective study indicated that allo-HSCT may be a feasible therapeutic option for SAA patients with infection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.